<DOC>
	<DOCNO>NCT00548288</DOCNO>
	<brief_summary>The aim study determine whether pamidronate apply locally cause diminished periprosthetic bone loss decrease rate bone turnover compare patient receive placebo cement total hip arthroplasty ( THA ) . The study design prospective , randomize , blind . Periprosthetic bone mineral density ( BMD ) measure dual energy X-ray absorptiometry ( DXA ) total periprosthetic area well seven Gruen zone region interest . DXA scan perform one week ( baseline ) , three month , six month postoperatively . Mean value biochemical marker bone turnover , BMD , baseline-normalized BMD value compare bisphosphonate placebo group time point . For temporal measurement include bone marker , BMD normalize BMD , mean value compare across time point within give group .</brief_summary>
	<brief_title>Effect Local Pamidronate Preventing Bone Loss After Total Hip Arthroplasty</brief_title>
	<detailed_description />
	<criteria>patient hip arthritis schedule total cemented hip arthroplasty pregnancy endoprosthesis contralateral hip</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>